Circular Normativa n.º 001/ERIS-DRS/2021
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Circular Normativa n.º 001/ERIS-DRS/2021 is the official ERIS identifier for “Certificação de laboratórios para testes rápidos de anticorpos e antigénio SARS-CoV-2”. Circular Normativa n.º 001/ERIS-DRS/2021 is the official identifier ERIS uses for this instrument.
- Instrument
- Circular
- Full name
- Circular Normativa n.º 001/ERIS-DRS/2021
- Category
- Registration
- Source publication
- Portuguese
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Certificação de laboratórios para testes rápidos de anticorpos e antigénio SARS-CoV-2
Complete six-page circular including all four pages of its integral laboratory safety annex. Data 15 February 2021 is issuance only; formal publication and effective dates are unverified. Requires prior ERIS laboratory service certification; antigen testing adds a premises/flow-plan document to the three antibody-test documents. Preserves staffing, biosafety, sampling, waste and reporting guidance. Its Resolution 169/2020 reference is not treated as proof of a current authorization: that original has a thirty-day term, and separately retained Resolutions 4/2021 and 20/2021 concern emergency-state and facility measures without themselves repeating the antigen-test authorization. Further legal continuity and present applicability remain under review. Waste-handling periods are not approval SLAs. This is laboratory-service certification, not a general IVD product modification process; later changes remain open.
Circular Normativa n.º 001/ERIS-DRS/2021 is the official identifier ERIS uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.